-
-
An expert opinion in speech and language therapy: The Queen Square Intensive Comprehensive Aphasia Programme
-
8th Sep 2020
-
Posted in Rehabilitation Articles
- Claire Farrington-Douglas and Alex Leff
-
-
SPRAVATO®▼ (esketamine) nasal spray for treatment-resistant major depressive disorder recommended in Scotland – but not England
-
3rd Sep 2020
-
Posted in Industry News
- News from Janssen Pharmaceuticals
-
-
Investigation of hereditary muscle disorders in the genomic era
-
19th Aug 2020
-
Posted in Australia/New Zealand,Clinical Review Article
- Roula Ghaoui and Merrilee Needham
-
-
Mass cytometry provides unprecedented insight into the role of B cells during the pathogenesis of multiple sclerosis
-
18th Aug 2020
-
Posted in Australia/New Zealand,Clinical Review Article
- Felix Marsh-Wakefield, Scott N Byrne, Simon Hawke and Georges Grau
-
-
Teva launches pre-filled pen for anti-CGRP migraine therapy AJOVY®▼ (fremanezumab) in the UK
-
8th Aug 2020
-
Posted in Headache,Industry News
- News from Teva
-
-
A month of Sundays? What technology can tell us about sleep on lockdown
-
6th Aug 2020
-
Posted in COVID-19 Articles,Online First,Sleep Series,Special Feature
- Alastair Paterson
-
-
COVID-19 Rehabilitation: UK data on rehabilitation needs & management pathways
-
5th Aug 2020
-
Posted in Courses & Conferences,COVID-19 Articles,Online First
- Webinar video
-
-
Occurrence of Balínt Syndrome in a patient with Hypereosinophilic Syndrome
-
5th Aug 2020
-
Posted in Case Reports,Online First
- Philipp Klocke, Anna Whalen-Browne, Mohamed Panju, Elliot Hepworth
-
-
Frontiers in Traumatic Brain Injury
-
5th Aug 2020
-
Posted in Courses & Conferences,Online First
- Juliet Reid
-
-
The many faces of COVID: Experiences of deployment and redeployment by Neurology Registrars
-
5th Aug 2020
-
Posted in Association of British Neurologists Trainees,COVID-19 Articles,Online First,Special Feature
- Richard N Rees, Mike Kemp, Srikirti Kodali
